We are live on ! Find out more
MAM

MPM Asset Management Portfolio holdings

AUM $44.5M
1-Year Est. Return 47.28%
This Fund
S&P 500
This Quarter Est. Return
+48.29%
1 Year Est. Return
-47.28%
3 Year Est. Return
+5.89%
5 Year Est. Return
-18.52%
10 Year Est. Return
+3.53%
AUM
$355M
AUM Growth
+$129M
Cap. Flow
+$44.7M
Cap. Flow %
12.6%
Top 10 Hldgs %
99.41%
Holding
11
New
1
Increased
1
Reduced
1
Closed
–

Top Buys

Rank Stock Value
1
PETX
Aratana Therapeutics, Inc.
PETX
+$43.8M
2
HSTO
Histogen Inc. Common Stock
HSTO
+$11.1M

Top Sells

Rank Stock Value
1
VSTM icon
Verastem
VSTM
+$10.2M

Sector Composition

Rank Sector Weight
1 Healthcare 94.76%
2 Miscellaneous 5.24%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
EPZM
1
DELISTED
Epizyme, Inc
EPZM
$115M 32.49%
2,880,485
– –
PETX
2
DELISTED
Aratana Therapeutics, Inc.
PETX
$71.1M 20.05%
4,351,048
+4,170,543
+2,310% +$43.8M
PTLA
3
DELISTED
Portola Pharmaceuticals, Inc.
PTLA
$65.3M 18.41%
2,441,344
– –
PCRX icon
4
Pacira BioSciences
PCRX
$1.05B
$39.6M 11.17%
824,255
– –
ALT icon
5
Altimmune
ALT
$665M
$13.3M 3.76%
21,159
– –
VSTM icon
6
Verastem
VSTM
$743M
$12.9M 3.63%
86,110
-58,571
-40% -$10.2M
HSTO
7
DELISTED
Histogen Inc. Common Stock
HSTO
$12M 3.38%
+5,960
New +$11.1M
KBIO
8
DELISTED
KALOBIOS PHARMACEUTICALS INC COM STK NEW (DE)
KBIO
$11.9M 3.36%
329,116
– –
ZLCS
9
DELISTED
ZALICUS INC COM NEW
ZLCS
$6.68M 1.88%
927,830
– –
AVEO
10
DELISTED
AVEO Pharmaceuticals, Inc.
AVEO
$4.55M 1.28%
220,896
– –
ETRM
11
DELISTED
EnteroMedics Inc.
ETRM
$2.09M 0.59%
1,590
– –

Similar funds

WCPI
Wynnchurch Capital Partners IV Rosemont, Illinois $44.8M AUM 11.91% 1-Year Est. Return
BAM
Broadcrest Asset Management Winter Park, Florida $44.1M AUM 4.51% 1-Year Est. Return
WAMC
Western Asset Management Company Pasadena, California $45.2M AUM 6.96% 1-Year Est. Return
NLVP
New Leaf Venture Partners New York $43M AUM 25.55% 1-Year Est. Return
CIEP
Constellation Investimentos e Participacoes Sao Paulo, Brazil $46.7M AUM 23.3% 1-Year Est. Return
IPI
Inflection Point Investments London, United Kingdom $46.9M AUM 18.35% 1-Year Est. Return
CC
Corton Capital Carrying Place, Ontario, Canada $40.7M AUM 52.32% 1-Year Est. Return
VSAM
Value Star Asset Management Hong Kong $49.2M AUM 60.1% 1-Year Est. Return

MPM Asset Management's Q3 2013 Portfolio in Review

As of Q3 2013, MPM Asset Management held 11 positions worth $355M, up 57% from $226M the previous quarter. Its ten largest holdings account for 99% of the portfolio.

MPM Asset Management deployed $44.7M of net new capital in Q3 2013, opening 1 new position and adding to 1 existing holding. Its largest new stake was Histogen Inc. Common Stock: 5,960 shares worth $12M.

By sector, the portfolio is most concentrated in Healthcare at 95% of assets, up from 92% a quarter earlier, followed by Miscellaneous.

On the sell side, the largest reduction was Verastem, an estimated $10.2M trimmed.

  • MPM Asset Management's largest Q3 2013 buy was Histogen Inc. Common Stock: 5,960 shares worth $12M.
  • MPM Asset Management added most to Aratana Therapeutics, Inc. in Q3 2013, an estimated $43.8M increase.
  • MPM Asset Management's biggest Q3 2013 reduction was Verastem, cutting an estimated $10.2M.
  • MPM Asset Management's ten largest holdings make up 99% of its $355M portfolio in Q3 2013.
  • MPM Asset Management opened 1 new position and closed 0 in Q3 2013.
  • MPM Asset Management's portfolio value rose 57% quarter-over-quarter to $355M.

Based on MPM Asset Management's 13F filing for Q3 2013, filed 26 Nov 2013.